ICW Makes a Substantial Strategic Commitment to Focus on the U.S. Market

InterComponentWareInterComponentWare AG (ICW), an international eHealth company headquartered in Walldorf, Germany, has invested substantially over the last two years to strongly focus on the current and future needs of the U.S. healthcare market, especially in the areas of Care Coordination and Care Management. Based on its mature, best-of-breed Health Information Exchange (HIE) and Master Patient Index (MPI) solutions, ICW has developed care management applications supporting care pathways across all venues, as well as applications for collaborative care coordination. Due to its considerable progress, ICW has decided to reopen their operations in the U.S with teams in business development, sales and product management. ICW Inc. is headquartered in Bala Cynwyd, PA, includes key representatives in the Northeast and Silicon Valley, and is led by board members Peter J. Kirschbauer (Chairman & CEO), Nils Effertz (Chief Business Development Officer & COO) and Matthias Glück (Chief Financial Officer), along with top U.S. industry advisors.

"The U.S. Health Information Technology (HIT) market has made tremendous progress over the past years and its dynamics provide excellent opportunities for us. We're excited about supporting critical progress in underlying technologies, a plethora of care delivery applications, and multiple stakeholder collaborations within a U.S. healthcare system that is increasingly shifting from fee-for-service to fee-for-value. Our go-to-market strategy will be centered around key strategic partnerships, which, as part of sustainably growing our U.S. organization, we'll complement with select direct initiatives to work closely with our valued U.S. customers in order to meet their needs and gather best practices for IT adoption in healthcare ," says Nils Effertz.

ICW delivers solutions ideally suited for risk bearing healthcare organizations such as Accountable Care Organizations (ACO), as well as Integrated Delivery Networks (IDN), Health Systems and HIE focused organizations. ICW's products are offered both via one-time and subscription-based licensing, benefiting from 15 years of strong HIT software development expertise from its Germany-based parent company, ICW AG.

"This is a great time to partner and work with ICW. We're convinced that ICW is at the beginning of a U.S. growth cycle and we’ll be 100% focused on helping our partners and clients succeed in adopting HIT that is fully aligned with their strategic goals and gets us closer to achieving the triple aim of healthcare: better care, lower costs and improved outcomes. ICW's full commitment to the U.S. is fostered by our strong belief that a majority of our revenue will come from the U.S. market over the next years," states Peter J. Kirschbauer.

Related news articles:

About InterComponentWare AG
We are a privately owned international software company with over 15 years of experience in the field of Healthcare IT. We are headquartered in Walldorf, Germany, have our own subsidiary in the U.S. and are strongly U.S. market focused. We build efficient and reliable solutions to improve the quality and efficiency of care across the entire care continuum. Our solutions enable healthcare organizations to leverage innovative models for cross-enterprise care coordination and patient-centric care delivery. We apply state-of-the-art software technology to develop robust and highly scalable applications with a strong focus on optimal user experience. We support the most advanced communication and interoperability standards by design, and turn seamless integration into a straightforward process. Together with our partners, we deliver safe and sustainable solutions for more than 20 million patients across the United States, Germany and Switzerland.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...